4.7 Article

Population-Level Relative Effectiveness of the COVID-19 Vaccines and the Contribution of Naturally Acquired Immunity

期刊

JOURNAL OF INFECTIOUS DISEASES
卷 227, 期 6, 页码 773-779

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiac483

关键词

COVID-19; SARS-CoV-2; booster; cumulative incidence; naturally acquired immunity; proportion of the population ever infected; seroprevalence; vaccine coverage; vaccine-induced immunity; waning antibodies

向作者/读者索取更多资源

Vaccination with the primary series was strongly associated with reduction in COVID-19 mortality at state level in the Alpha, Delta, and Omicron wave. This effect did not vary by the state-level seroprevalence or estimated proportion of the population ever infected.
Vaccination with the primary series was strongly associated with reduction in COVID-19 mortality at state level in the Alpha, Delta, and Omicron wave. This effect did not vary by the state-level seroprevalence or estimated proportion of the population ever infected. Background Immune protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be induced by natural infection or vaccination or both. Interaction between vaccine-induced immunity and naturally acquired immunity at the population level has been understudied. Methods We used regression models to evaluate whether the impact of coronavirus disease 2019 (COVID-19) vaccines differed across states with different levels of naturally acquired immunity from March 2021 to April 2022 in the United States. Analysis was conducted for 3 evaluation periods separately (Alpha, Delta, and Omicron waves). As a proxy for the proportion of the population with naturally acquired immunity, we used either the reported seroprevalence or the estimated proportion of the population ever infected in each state. Results COVID-19 mortality decreased as coverage of >= 1 dose increased among people >= 65 years of age, and this effect did not vary by seroprevalence or proportion of the total population ever infected. Seroprevalence and proportion ever infected were not associated with COVID-19 mortality, after controlling for vaccine coverage. These findings were consistent in all evaluation periods. Conclusions COVID-19 vaccination was associated with a sustained reduction in mortality at state level during the Alpha, Delta, and Omicron periods. The effect did not vary by naturally acquired immunity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据